Novartis AG EBIT 2010-2024 | NVS

Novartis AG EBIT for the quarter ending June 30, 2024 was $4.014B, a 43% increase year-over-year.

  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.
  • Novartis AG 2021 EBIT was 11.689B, a 15.14% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Novartis AG EBIT 2010-2024 | NVS

  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.
  • Novartis AG 2021 EBIT was 11.689B, a 15.14% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B